SCHEMBL24336248

SCHEMBL24336248

O=C(Nc1ccn(Cc2ccncc2)n1)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.72
LMNA P02545 4/20 0.72
NPSR1 Q6W5P4 2/20 0.72
TSHR P16473 1/20 0.72
HTT P42858 1/20 0.72
NPC1 O15118 5/20 0.63
RAB9A P51151 5/20 0.63
ALDH1A1 P00352 4/20 0.63
HIF1A Q16665 3/20 0.58
EPAS1 Q99814 3/20 0.58
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
LDHB P07195 1/20 0.52
MAPK1 P28482 2/20 0.50
TP53 P04637 1/20 0.48
CACNA1G O43497 1/20 0.47
CACNA1I Q9P0X4 1/20 0.47
STIM1 Q13586 1/20 0.47
ORAI1 Q96D31 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24335756 0.89 SMN1; SMN2 (0.91) SMN1; SMN2LMNANPSR1TSHRHTT
SCHEMBL24336249 0.89 SMN1; SMN2 (0.74) SMN1; SMN2LMNANPSR1TSHRHTT
SCHEMBL24335575 0.89 SMN1; SMN2 (0.73) SMN1; SMN2LMNANPSR1TSHRHTT
SCHEMBL24336241 0.86 LMNA (0.70) SMN1; SMN2LMNANPSR1TSHRHTT
SCHEMBL24335934 0.86 SMN1; SMN2 (0.79) SMN1; SMN2LMNANPSR1TSHRHTT
SCHEMBL24335950 0.83 SMN1; SMN2 (0.66) SMN1; SMN2LMNANPSR1TSHRHTT
SCHEMBL24336245 0.83 SMN1; SMN2 (0.66) SMN1; SMN2LMNANPSR1TSHRHTT
SCHEMBL24335772 0.82 SMN1; SMN2 (0.60) SMN1; SMN2LMNANPSR1TSHRHTT
SCHEMBL24335591 0.82 SMN1; SMN2 (0.64) SMN1; SMN2LMNANPSR1TSHRHTT
SCHEMBL24335955 0.81 SMN1; SMN2 (0.57) SMN1; SMN2LMNANPSR1TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116438171-A Substituted pyridine derivatives as SARM1 inhibitors 努拉生物公司 2023-07-14 CN claimed
CN-116438171-A Substituted pyridine derivatives as SARM1 inhibitors 努拉生物公司 2023-07-14 CN disclosed
US-20220081417-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS NURA BIO, INC. 2022-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220081417-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS SARM1, SARNP, ADRM1 SMN1; SMN2 7/4885LMNA 1963/4885NPSR1 4420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.